ER-alpha and ER-beta expression in differentiated thyroid cancer: relation with tumor phenotype across the TNM staging and peri-tumor inflammation

Endocrine

Volumn 49, Issue 2, 2015, Pages 429-435

  Magri, Flavia ^a   Capelli, Valentina ^a   Gaiti, Margherita ^a   Villani, Laura ^b   Zerbini, Francesca ^a   La Manna, Luigi ^b   Rotondi, Mario ^a   Chiovato, Luca ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b IRCCS   (Italy)

Author keywords

Estrogen receptor; Risk assessment; Thyroid cancer; Tumoral inflammation

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR ALPHA, HUMAN;

ADULT; AGED; AGGRESSIVENESS; ARTICLE; CANCER INFILTRATION; CANCER RISK; CANCER STAGING; CAPSULAR INVASION; CELL INFILTRATION; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PERI TUMOR INFLAMMATORY INFILTRATE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; TUMOR GROWTH; TUMOR INVASION; TUMOR VOLUME; VASCULAR INVASION; GENE EXPRESSION REGULATION; INFLAMMATION; METABOLISM; MIDDLE AGED; THYROID TUMOR; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NEOPLASM STAGING; PHENOTYPE; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84929951228     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-014-0457-x     Document Type: Article

References (27)

1. R. Bonacci, A. Pinchera, P. Fierabracci, A. Gigliotti, L. Grasso, C. Giani, Relevance of estrogen and progesterone receptors enzyme immunoassay in malignant, benign and surrounding normal thyroid tissue. J. Endocrinol. Invest. 19(3), 159–164 (1996)
2. F. Magri, V. Capelli, M. Rotondi, P. Leporati, L. La Manna, R. Ruggiero, A. Malovini, R. Bellazzi, L. Villani, L. Chiovato, Expression of estrogen and androgen receptors in differentiated thyroid cancer: an additional criterion to assess the patient’s risk. Endocr. Relat. Cancer 19(4), 463–471 (2012)
3. G.G. Chen, A.C. Vlantis, Q. Zeng, C.A. van Hasselt, Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer. Curr. Cancer Drug Targets 8(5), 367–377 (2008)
4. Q. Zeng, G.G. Chen, A.C. Vlantis, C.A. van Hasselt, Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway. Cell Prolif. 40(6), 921–935 (2007)
5. Q. Zeng, G. Chen, A. Vlantis, G. Tse, C. van Hasselt, The contributions of oestrogen receptor isoforms to the development of papillary and anaplastic thyroid carcinomas. J. Pathol. 214(4), 425–433 (2008)
6. A. Heikkila, J. Hagstrom, H. Maenpaa, J. Louhimo, P. Siironen, I. Heiskanen, C. Haglund, J. Arola, Loss of estrogen receptor Beta expression in follicular thyroid carcinoma predicts poor outcome. Thyroid 23(4), 456–465 (2013)
7. S. Xu, G. Chen, W. Peng, K. Renko, M. Derwahl, Oestrogen action on thyroid progenitor cells: relevant for the pathogenesis of thyroid nodules? J. Endocrinol. 218(1), 125–133 (2013)
8. M.L. Lee, G.G. Chen, A.C. Vlantis, G.M. Tse, B.C. Leung, C.A. van Hasselt, Induction of thyroid papillary carcinoma cell proliferation by estrogen is associated with an altered expression of Bcl-xL. Cancer J. 11(2), 113–121 (2005)
9. D. Manole, B. Schildknecht, B. Gosnell, E. Adams, M. Derwahl, Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J. Clin. Endocrinol. Metab. 86(3), 1072–1077 (2001)
10. S. Rajoria, R. Suriano, A. Shanmugam, Y.L. Wilson, S.P. Schantz, J. Geliebter, R.K. Tiwari, Metastatic phenotype is regulated by estrogen in thyroid cells. Thyroid 20(1), 33–41 (2010)
11. M. Tafani, E. De Santis, L. Coppola, G.A. Perrone, I. Carnevale, A. Russo, B. Pucci, A. Carpi, M. Bizzarri, M.A. Russo, Bridging hypoxia, inflammation and estrogen receptors in thyroid cancer progression. Biomed. Pharmacother. 68(1), 1–5 (2014)
12. J.S. Lewis-Wambi, V.C. Jordan, Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit? Breast Cancer Res. 11(3), 206 (2009)
13. M. Pradhan, S.C. Baumgarten, L.A. Bembinster, J. Frasor, CBP mediates NF-κB-dependent histone acetylation and estrogen receptor recruitment to an estrogen response element in the BIRC3 promoter. Mol. Cell. Biol. 32(2), 569–575 (2012)
14. R. Chu, A. van Hasselt, A.C. Vlantis, E.K. Ng, S.Y. Liu, M.D. Fan, S.K. Ng, A.B. Chan, Z. Liu, X.Y. Li et al., The cross-talk between estrogen receptor and peroxisome proliferator-activated receptor gamma in thyroid cancer. Cancer 120(1), 142–153 (2014)
15. D. Hanahan, R.A. Weinberg, Hallmarks of cancer: the next generation. Cell 144(5), 646–674 (2011)
16. F. Liotti, C. Visciano, R.M. Melillo, Inflammation in thyroid oncogenesis. Am J Cancer Res 2(3), 286–297 (2012)
17. L.L. Cunha, M.A. Marcello, L.S. Ward, The role of the inflammatory microenvironment in thyroid carcinogenesis. Endocr. Relat. Cancer 21(3), 85–103 (2013)
18. A. Proietti, C. Ugolini, R.M. Melillo, G. Crisman, R. Elisei, M. Santoro, M. Minuto, P. Vitti, P. Miccoli, F. Basolo, Higher intratumoral expression of CD1a, tryptase, and CD68 in a follicular variant of papillary thyroid carcinoma compared to adenomas: correlation with clinical and pathological parameters. Thyroid 21(11), 1209–1215 (2011)
19. E. De Santis, M. Di Vito, G.A. Perrone, E. Mari, M. Osti, E. De Antoni, L. Coppola, M. Tafani, A. Carpi, M.A. Russo, Overexpression of pro-inflammatory genes and down-regulation of SOCS-1 in human PTC and in hypoxic BCPAP cells. Biomed. Pharmacother. 67(1), 7–16 (2013)
20. M. Clemons, P. Goss, Estrogen and the risk of breast cancer. N. Engl. J. Med. 344(4), 276–285 (2001)
21. D. Rades, C. Setter, O. Dahl, S.E. Schild, F. Noack, The prognostic impact of tumor cell expression of estrogen receptor-alpha, progesterone receptor, and androgen receptor in patients irradiated for non-small cell lung cancer. Cancer 118(1), 157–163 (2011)
22. M. Barone, K. Lofano, N. De Tullio, R. Licino, F. Albano, A. Di Leo, Dietary, endocrine, and metabolic factors in the development of colorectal cancer. J Gastrointest Cancer 43(1), 13–19 (2012)
23. A. Bardin, N. Boulle, G. Lazennec, F. Vignon, P. Pujol, Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr. Relat. Cancer 11(3), 537–551 (2004)
24. Y. Huang, W. Dong, J. Li, H. Zhang, Z. Shan, W. Teng, Differential expression patterns and clinical significance of estrogen receptor-alpha and beta in papillary thyroid carcinoma. BMC Cancer 14, 383 (2014)
25. S. Chu, Y. Nishi, T. Yanase, H. Nawata, P.J. Fuller, Transrepression of estrogen receptor beta signaling by nuclear factor-kappab in ovarian granulosa cells. Mol. Endocrinol. 18(8), 1919–1928 (2004)
26. F. Pacifico, A. Leonardi, Role of NF-kappaB in thyroid cancer. Mol. Cell. Endocrinol. 321(1), 29–35 (2010)
27. W.H. Sun, E.T. Keller, B.S. Stebler, W.B. Ershler, Estrogen inhibits phorbol ester-induced I kappa B alpha transcription and protein degradation. Biochem Biophys Res Commun 244(3), 691–695 (1998)